Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
105.00    13.60 (14.88%)
Bid:
103.80
Ask:
106.20
Spread: 2.40 (2.312%)
Market Cap: £441.37m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

Interim Management Statement

14 Apr 2011 07:00

RNS Number : 8629E
PZ CUSSONS PLC
14 April 2011
 



14 April 2011

PZ Cussons Plc

(the "Group")

 

Interim Management Statement

 

PZ Cussons Plc today issues the following interim management statement which covers the period 26th January 2011 to 13th April 2011.

 

Overview of financial performance and position

 

PZ Cussons Plc announces that results for the period have been broadly in line with management expectations, despite challenging trading conditions in some markets and continued high levels of raw material costs.

 

The Group's balance sheet remains healthy with a net funds position and good cash generation during the period.

 

Trading Update

 

Europe

 

In the UK, trading conditions remain challenging with high levels of promotional activity and a continuing squeeze on consumer spending. This is particularly noticeable in areas such as shower gels and handwash. The more premium brands under the newly formed PZ Cussons Beauty division, namely The Sanctuary, St Tropez and Charles Worthington have continued to perform well.

 

Trading conditions in Poland and Greece also remain challenging due to a difficult consumer environment.

 

Asia

 

The Asia region as a whole continues to perform strongly, and whilst the Australian consumer environment has tightened, the relaunch of Cussons Baby in Indonesia is continuing to drive profitable growth.

 

Africa

 

After some initial delays, the Nigerian election process has now begun with the presidential elections expected to be complete by the end of April. Whilst underlying sales rates during the period have improved, some further disruption to trading from the election process is expected during the remainder of the financial year coinciding with the traditionally peak sales months.

 

Exceptional Items

 

These will include transaction costs associated with the acquisition of St Tropez together with further costs associated with the restructuring of the business as anticipated.

 

In addition, exceptional items will include a charge in relation to the enhanced transfer value exercise being conducted in relation to the closed UK based final salary pension schemes and a credit reflecting the change in statutory minimum pension increases from RPI to CPI.

 

Major initiatives

 

In the UK, the formation of the PZ Cussons Beauty division which was announced in February, is on track and expected to be fully operational by 1 June.

 

In Nigeria, initial work on the food and nutrition joint venture with Wilmar International has now begun.

 

Outlook

 

The trading outlook for the remainder of the current financial year remains challenging and is expected to be impacted by the UK trading environment, the temporary delay to Nigeria's election process and continued high levels of raw material costs.

 

These factors will be partially offset by the resilience of our more premium brands in the UK, by the growth in Asia and by the underlying improvement in demand in Nigeria, all of which give cause for encouragement for the next financial year.

 

A further trading update will be made on 9th June 2011 after the close of the financial year.

 

 

Enquiries:

 

PZ Cussons Plc

Brandon Leigh Tel: 0161 435 1016

 

MHP Communications

John Olsen / James White Tel: 020 3128 8100

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSDKNDKQBKDFQD
Date   Source Headline
2nd Aug 20076:07 pmRNSDirector/PDMR Shareholding
31st Jul 20077:01 amRNSFinal Results
7th Jun 20077:01 amRNSTrading Statement
17th May 20077:01 amRNSNotice of trading update
19th Apr 200710:41 amRNSHolding(s) in Company
2nd Apr 20079:58 amRNSDirector/PDMR Shareholding
20th Mar 200711:57 amRNSHolding(s) in Company
13th Mar 20077:01 amRNSGPB26m investment
14th Feb 20079:59 amRNSHolding(s) in Company
30th Jan 20077:01 amRNSInterim Results
19th Dec 200611:40 amRNSDirectorate Change
19th Dec 200611:37 amRNSTotal Voting Rights
30th Nov 20067:01 amRNSTrading Statement
26th Sep 20067:02 amRNSResult of AGM
25th Sep 200612:00 pmRNSAGM Statement
19th Sep 20061:30 pmRNSDirector/PDMR Shareholding
4th Sep 20064:14 pmRNSGrant of Options
1st Aug 20067:00 amRNSFinal Results
1st Jun 20069:00 amRNSDirectorate Change
1st Jun 20067:01 amRNSPre-Close Update
6th Apr 20064:34 pmRNSDirectors interest in Shares
5th Apr 20061:09 pmRNSDirectors Interest in Shares
22nd Mar 200612:25 pmRNSDirectors Interest in Shares
3rd Mar 200611:30 amRNSDirectors Interest in Shares
1st Mar 20067:01 amRNSDirectorate Change
9th Feb 20068:48 amRNSDirector/PDMR Shareholding
7th Feb 20067:01 amRNSInterim Results
24th Jan 20067:00 amRNSNotice of Results
3rd Jan 20067:30 amRNSDirector Declaration
4th Oct 20059:00 amRNSDirectorate Change
3rd Oct 200510:20 amRNSDirectorate Change
26th Sep 200512:00 pmRNSAGM Statement
19th Sep 20053:21 pmRNSDirectors Interest in Shares
9th Sep 200510:36 amRNSDirectors Interest in Shares
8th Sep 200512:40 pmRNSDirectors Interest in Shares
24th Aug 20052:34 pmRNSDirectors Interest in Shares
15th Aug 20054:10 pmRNSDirectors Interest in Shares
2nd Aug 20057:01 amRNSFinal Results
28th Jul 20053:31 pmRNSNotice of Results
22nd Jul 200511:00 amRNSDirectorate Change
28th Jun 200512:35 pmRNSResult of Meetings
7th Jun 200512:00 pmRNSDirectorate Change
3rd Jun 20051:20 pmRNSNotice of EGM
2nd Jun 20057:01 amRNSProposed enfranchisement
1st Jun 20059:00 amRNSDirector Declaration
5th May 200512:00 pmRNSDirectorate Change
9th Mar 20054:43 pmRNSSecond Price Monitoring Extn
9th Mar 20054:38 pmRNSPrice Monitoring Extension
8th Feb 20057:00 amRNSInterim Results
10th Jan 20051:09 pmRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.